We are live on ! Find out more
SNDX icon

Syndax Pharmaceuticals
SNDX

142 hedge funds and large institutions have $1.03B invested in Syndax Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 50 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 11

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

144% more call options, than puts

Call options by funds: $8.49M | Put options by funds: $3.48M

110% more capital invested

Capital invested by funds: $493M → $1.03B (+$541M)

108% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 24

43% more funds holding

Funds holding: 99 → 142 (+43)

11.63% more ownership

Funds ownership: 88.81% → 100.43% (+12%)

Holders
142
Holders Change
+43
Holders Change %
+43.43%
% of All Funds
2.51%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
55
Increased
50
Reduced
24
Closed
11
Calls
$8.49M
Puts
$3.48M
Net Calls
+$5.01M
Net Calls Change
+$5.13M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$32.1M
2
APM
Avidity Partners Management
Texas
+$30.2M
3
EAM
Eventide Asset Management
Massachusetts
+$25.9M
4
HM
HealthCor Management
New York
+$21.5M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.3M

Top Sellers

1
BI
BVF Inc
California
-$33M
2
MAM
MPM Asset Management
Massachusetts
-$27.2M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$14.8M
4
CS
Candriam SCA
Luxembourg
-$6.9M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
51
Janus Henderson Group
United Kingdom
$2.9M +$2.71M +130,458 New
PCM
52
Pinz Capital Management
New York
$2.81M +$2.62M +126,352 New
TLP
53
Tri Locum Partners
New York
$2.64M +$2.46M +118,833 New
MWNA
54
Marshall Wace North America
New York
$2.56M +$2.39M +115,322 New
PAM
55
Panagora Asset Management
Massachusetts
$2.45M +$1.14M +55,020 +100%
Russell Investments Group
56
Russell Investments Group
United Kingdom
$2.38M -$378K -18,247 -15%
EGI
57
EAM Global Investors
California
$2.21M +$2.07M +99,573 New
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$2.11M +$1.83M +88,451 +1,411%
Squarepoint
59
Squarepoint
New York
$2.03M +$532K +25,643 +39%
Verition Fund Management
60
Verition Fund Management
Connecticut
$1.97M +$1.84M +88,595 New
WP
61
Woodline Partners
California
$1.73M +$1.61M +77,699 New
Swiss National Bank
62
Swiss National Bank
Switzerland
$1.63M +$1.52M +73,200 New
EI
63
EAM Investors
California
$1.57M +$1.47M +70,666 New
Wells Fargo
64
Wells Fargo
California
$1.38M -$13.9K -670 -1%
Morgan Stanley
65
Morgan Stanley
New York
$1.36M +$381K +18,362 +43%
California Public Employees Retirement System
66
California Public Employees Retirement System
California
$1.33M -$24.9K -1,200 -2%
CS
67
Credit Suisse
Switzerland
$1.24M -$126K -6,059 -10%
Jane Street
68
Jane Street
New York
$1.18M +$1.1M +52,846 New
CCMW
69
Cypress Capital Management (Wyoming)
Wyoming
$1.14M +$1.07M +51,430 New
State of Wisconsin Investment Board
70
State of Wisconsin Investment Board
Wisconsin
$1.13M -$145K -7,000 -12%
Bank of America
71
Bank of America
North Carolina
$1.04M +$436K +21,001 +82%
QSS
72
Quantitative Systematic Strategies
Florida
$960K +$609K +29,351 +213%
Ensign Peak Advisors
73
Ensign Peak Advisors
Utah
$911K – – –
California State Teachers Retirement System (CalSTRS)
74
California State Teachers Retirement System (CalSTRS)
California
$905K – – –
MIM
75
Monashee Investment Management
Massachusetts
$890K +$830K +40,000 New
1 2
3
4 5

SNDX Hedge Fund Activity: Q4 2020 in Review

142 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Syndax Pharmaceuticals (SNDX) for Q4 2020, worth a combined $1.03B — up 110% from $493M a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new SNDX positions and 11 closed out — a net gain of 44 holders — while 50 added to existing stakes and 24 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $32.1M. The largest seller was BVF Inc, cutting an estimated $33M.

  • 142 institutional investors held Syndax Pharmaceuticals (SNDX) as of Q4 2020, up from 99 in Q3 2020.
  • Funds reported $1.03B of Syndax Pharmaceuticals stock for Q4 2020, up 110% quarter-over-quarter.
  • 55 funds opened new Syndax Pharmaceuticals positions in Q4 2020 and 11 closed out, a net change of +44 holders.
  • The largest Syndax Pharmaceuticals buyer in Q4 2020 was Citadel Advisors, an estimated $32.1M added.
  • The largest Syndax Pharmaceuticals seller in Q4 2020 was BVF Inc, an estimated $33M sold.

Based on aggregated 13F filings for Q4 2020.